Results from Clinical Study in Young Adults with Down Syndrome

Transition's wholly-owned subsidiary, Transition Therapeutics Ireland Limited ("TTIL") completed this first study in Down syndrome subjects without dementia to allow optimal dose selection for future larger studies.
Source: Disabled World - Category: Disability Tags: Clinical Trials Source Type: news